申请人:Amgen Inc.
公开号:US10519146B2
公开(公告)日:2019-12-31
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
本文提供了 K
RAS G12C
抑制剂、其组合物以及使用方法。这些
抑制剂可用于治疗多种疾病,包括胰腺癌、结直肠癌和肺癌。